Nurse Practitioner · Avondale, AZ
NPI
1982071429
Since 2015
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
13065 W. McDowell Rd Ste B-108
Avondale, AZ, 85392
Phone (623) 512-4320
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
433 services
Medicare patients, 2024
291
Average age 73
Drug cost, 2024
$2.2M
2,250 prescriptions
Company payments, 2025
$8,427
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Helena M in'T Veld was code 99214 (office e&m - established), 197 times for 136 patients. In total Helena M in'T Veld billed 433 services in 8 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 197 | 136 | $76.41 | $15K |
| 99213 Office E&M - Established | Office | 116 | 95 | $49.13 | $5,699 |
| 99204 Office E&M - New | Office | 53 | 53 | $93.61 | $4,961 |
| 99203 Office E&M - New | Office | 27 | 27 | $68.47 | $1,849 |
| 99212 Office E&M - Established | Office | 24 | 24 | $29.19 | $700 |
By year: 2022 $35K for 468 services; 2023 $31K for 463 services; 2024 $29K for 433 services.
Medicare prescription drug claims, 2024
In 2024, the drug Helena M in'T Veld prescribed most often to Medicare patients was Famotidine, with 500 prescriptions and refills. In total Helena M in'T Veld wrote 2,250 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 500 | 1,256 | 181 | $11K |
| Pantoprazole Sodium Generic | 468 | 1,227 | 172 | $5,304 |
| Omeprazole Generic | 179 | 450 | 66 | $2,718 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 85 | 85 | 82 | $1,338 |
| Linzess Linaclotide | 51 | 109 | 24 | $58K |
| Colestipol Hcl Generic | 48 | 103 | 19 | $4,542 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 44 | 44 | 42 | $2,906 |
| Lubiprostone Generic | 41 | 101 | 19 | $7,935 |
| Zenpep Lipase/Protease/Amylase | 37 | 59 | 14 | $187K |
| Esomeprazole Magnesium Generic | 36 | 100 | 14 | $1,418 |
| Ondansetron Odt Ondansetron | 34 | 34 | 12 | $1,042 |
| Xifaxan Rifaximin | 32 | 32 | 19 | $74K |
| Dicyclomine Hcl Generic | 30 | 41 | 18 | $449 |
| Dexlansoprazole Dr Dexlansoprazole | 30 | 53 | Under 11 | $7,712 |
| Sucraid Sacrosidase | 30 | 30 | Under 11 | $423K |
Brand drugs: 467 claims; generic drugs: 1,783 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Helena M in'T Veld $8,427 ($8,427 in general payments such as food, travel and fees) from 14 companies. The largest payer was QOL Medical, LLC with $5,902.
| Company | Payments | Amount |
|---|---|---|
| QOL Medical, LLC | 19 | $5,902 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $1,156 |
| Janssen Biotech, Inc. JNJ | 11 | $427 |
| Abbvie Inc. ABBV | 12 | $268 |
| Aimmune Therapeutics, Inc. | 5 | $159 |
| Madrigal Pharmaceuticals MDGL | 3 | $110 |
| Genzyme Corporation SNY | 3 | $110 |
| Pfizer Inc. PFE | 3 | $83.76 |
| Ardelyx, Inc. ARDX | 3 | $60.76 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $37.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.